Catabasis Pharmaceuticals, Inc. To Present At The Oppenheimer 26th Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage drug development company built on a pathway pharmacology technology platform, today announced that company management will present at the Oppenheimer 26th Annual Healthcare Conference. The Oppenheimer 26th Annual Healthcare Conference will be held December 8 - 9, 2015, at the Westin New York Grand Central Hotel in New York.

Back to news